Top 6 Stocks On My Shopping List as Market Calls for Strategy Change
It’s time to change strategy as earnings season closes and seasonal weakness creeps in.
The Bond Market Has Doubts About This Rally
Stocks are celebrating a softer rate outlook but the bond market is flashing warnings, oil is cranking higher, and we’re bracing for the CPI report.
Slowing Market Offers Glimpse of Near Future
Without any catalysts on the horizon, Monday offered a taste of what’s to come.
This Psychedelic Biotech Play Could See a Leg Up After Encouraging LSD Trials
The speculative action is cooling but individual names keep working.
Positive Price Action Smacks Into a Tough Calendar, Few Catalysts
The technical strength is impressive, but it requires a diet of positive news to sustain the momentum.
One-Size-Fits-All Might Work for Shirts. But Not for Trading
Let me tell you how to approach trading that actually works, and a secret about how under-the-radar small caps can become true winners — if you know what you’re doing.
Why Investors Are Celebrating the Poor Jobs Report
Weak payrolls cut the odds of a Fed hike, and that attracted buyers.
Respect the Rally, Question the Sustainability
We have the biggest weekly gains since April, but a number of negative catalysts are lurking.
It’s Hard to Be Bearish With This Many Stocks Making Big Moves
The indices stalled while 150 stocks gained more than 10%.
I’m Eyeing 2 Biopharma Stocks Amid Choppy Market Action
These small-cap biotechs offer core businesses that fund a much bigger opportunity.